ATE284894T1 - L-pyranosyl-nukleoside - Google Patents

L-pyranosyl-nukleoside

Info

Publication number
ATE284894T1
ATE284894T1 AT95938872T AT95938872T ATE284894T1 AT E284894 T1 ATE284894 T1 AT E284894T1 AT 95938872 T AT95938872 T AT 95938872T AT 95938872 T AT95938872 T AT 95938872T AT E284894 T1 ATE284894 T1 AT E284894T1
Authority
AT
Austria
Prior art keywords
pyranosyl
nucleosides
beta
alpha
methods
Prior art date
Application number
AT95938872T
Other languages
English (en)
Inventor
Alexander L Weis
Charles T Goodhue
Original Assignee
Genencor Int
Lipitek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor Int, Lipitek Inc filed Critical Genencor Int
Application granted granted Critical
Publication of ATE284894T1 publication Critical patent/ATE284894T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT95938872T 1994-10-24 1995-10-24 L-pyranosyl-nukleoside ATE284894T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32793294A 1994-10-24 1994-10-24
PCT/US1995/013717 WO1996012728A1 (en) 1994-10-24 1995-10-24 L-pyranosyl nucleosides

Publications (1)

Publication Number Publication Date
ATE284894T1 true ATE284894T1 (de) 2005-01-15

Family

ID=23278709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95938872T ATE284894T1 (de) 1994-10-24 1995-10-24 L-pyranosyl-nukleoside

Country Status (7)

Country Link
US (1) US5885972A (de)
EP (1) EP0788507B1 (de)
JP (1) JPH10507763A (de)
AT (1) ATE284894T1 (de)
DE (1) DE69533856T2 (de)
MX (1) MX9702927A (de)
WO (1) WO1996012728A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997000882A1 (en) * 1995-06-23 1997-01-09 Oxford Glycosciences (Uk) Limited Therapeutic compounds
DE19741738A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Linker-Nucleosid, seine Herstellung und Verwendung
DE19741715A1 (de) 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
DE19837387A1 (de) 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
US8366909B2 (en) * 2009-02-26 2013-02-05 Chevron U.S.A. Inc. Reforming process at low pressure
CN102742005B (zh) * 2009-10-14 2016-04-20 阿德科产品有限责任公司 具有平衡的性质的边缘密封剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1620185C3 (de) * 1966-03-02 1982-01-14 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen 5-Äthyl- und 5-Propyl-2'-deoxyuridin, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende Arzneimittel
US3457255A (en) * 1967-05-17 1969-07-22 Syntex Corp Novel ribo and lyxo nucleoside derivatives and a process for their preparation
CS164401B1 (en) * 1971-10-07 1975-11-07 Jiri Beranek Method of 1-beta-d-arabinofuranosylcytosine's preparation
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
CA1135258A (en) * 1979-06-15 1982-11-09 Richard D'souza Process for the preparation of 5'deoxy-5-fluorouridine
FR2528311B1 (fr) * 1982-06-14 1985-06-14 Synthelabo Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
EP0199451B1 (de) * 1985-03-16 1996-03-06 The Wellcome Foundation Limited Therapeutische Nukleoside
DK224286A (da) * 1985-05-15 1986-11-16 Wellcome Found 2',3'-dideoxy-nucleosider
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
KR960001372B1 (ko) * 1986-09-24 1996-01-26 예일 유니버시티 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
US4918056A (en) * 1986-10-14 1990-04-17 Health Research, Inc. (Roswell Park Division) 2-substituted arabinopyranosyl nucleosides and nucleotides
US4880782A (en) * 1986-11-21 1989-11-14 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Method of treating viral infections in humans and compositions therefor
SE8605503D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel medicinal use
EP0285884A3 (de) * 1987-03-20 1990-07-04 Bristol-Myers Squibb Company Verfahren zur Herstellung von 2',3'-Dideoxynucleoside
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
DE3900964A1 (de) * 1989-01-14 1990-07-19 Boehringer Mannheim Gmbh Neue nukleoside, verfahren zu deren herstellung sowie arzneimittel, die diese verbindungen enthalten
DD296281A5 (de) * 1990-07-01 1991-11-28 Akademie Der Wissenschaften Der Ddr,De Verfahren zur herstellung von neuen purinnukleosiden
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
WO1993003733A1 (en) * 1991-08-12 1993-03-04 Basco, Ltd. Syntheses, pharmaceutical composition and method of application of (2'-5') oligoadenylate analogues

Also Published As

Publication number Publication date
EP0788507A1 (de) 1997-08-13
WO1996012728A1 (en) 1996-05-02
EP0788507B1 (de) 2004-12-15
MX9702927A (es) 1998-04-30
US5885972A (en) 1999-03-23
JPH10507763A (ja) 1998-07-28
DE69533856T2 (de) 2005-12-08
DE69533856D1 (de) 2005-01-20

Similar Documents

Publication Publication Date Title
CA2372085A1 (en) L-ribo-lna analogues
DE60122285D1 (de) Methonocarbacycloalkylanaloga von nucleosiden
NO975585L (no) C-4' modifiserte adenosin-kinase inhibitorer
FI932870A0 (fi) 2'-deoxi-2'2'-difluor-(4-substituerad pyrimidin)nukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
DE69116750T2 (de) 9-Purinyl-Phosphonsäurederivate
ATE432284T1 (de) Einen starren linker enthaltende nukleotide
FR2596761B1 (fr) Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
DK0679657T3 (da) Nukleosider og oligonukleotider med 2'-ethergrupper
HK1085219A1 (en) Inhibitors of nucleoside phosphorylases and nucleosidases
PT1280813E (pt) Analogos de nucleosidos de pirimidina antivirais
KR890008161A (ko) 2',3'-디데옥시-2'-플루오로뉴클레오사이드류
DE69024804D1 (de) Antivirale zusammensetzung
DE69533856D1 (de) L-pyranosyl-nukleoside
Yoshimura et al. Synthesis and biological activities of 2′-deoxy-2′-fluoro-4′-thioarabinofuranosylpyrimidine and-purine nucleosides
ZA931647B (en) Therapeutic nucleosides
FI932868A0 (fi) 2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
Jung et al. New approach to the synthesis of. beta.-2'-deoxyribonucleosides: intramolecular Vorbrueggen coupling
ES2166081T3 (es) Derivados de nucleosidos con grupos protectores fotolabiles.
DE69406943D1 (de) Konformationell festgelegte nukleosidanaloge
ATE131826T1 (de) Anti-hiv pyrimidin nucleoside
NO984124L (no) FremgangsmÕte for Õ hemme adenylsuksinatsyntetaseaktivitet i metyltioadenosinfosforylasemanglende celler
DE60044937D1 (de) Analoge des 5(e)bromovinyluracils und verwandte pyrimidinnucleoside als antivirale mittel und verwendungsmethoden
KR960701639A (ko) 심기능 회복제(heart function restorative)
KR900700498A (ko) 항종양 6-술펜아미드, 6-술핀아미드 및 6-술폰아미드퓨린, 퓨린 뉴클레오시드, 퓨린 뉴클레오티드 및 관련 화합물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties